In Other News

More Headlines

 
 
 

Upcoming Events

06/20/13- 06/23/13
Emergency Medicine & Acute Care A Critical Appraisal
New York, New York



06/21/13- 06/22/13
Lifestyle Medicine: Tools for Promoting Healthy Change
Boston, Massachusetts

06/21/13- 06/23/13
Advanced Wilderness Life Support
Jackson, Wyoming

More Meetings & Events

 

Preventing Migraine Attacks

<p>
	Could an Antibody Prevent Migraine?</p>

Could an Antibody Prevent Migraine?

To prevent migraine attacks, neurologists commonly prescribe drugs designed to treat epilepsy, high blood pressure, or depression. Monoclonal antibodies currently in development could one day become the first prophylactic therapies... More

NIH Promotes Neuroscience

<p>
	BRAIN Initiative Seeks to Map the Human Brain</p>

BRAIN Initiative Seeks to Map the Human Brain

President Obama is calling on neuroscientists inside and outside the federal government to join an ambitious effort to understand and map the activity of the human brain.

... More

Audiocast

<p>
	Concussion, Depression, and the NFL</p>

Concussion, Depression, and the NFL

Nyaz Didehbani, PhD, discusses the connection between concussion and depression among former players from the National Football League.

... More

AAN 2013 Meeting

<p>
	AAN Releases Updated Sports Concussion Guideline</p>

AAN Releases Updated Sports Concussion Guideline

SAN DIEGO—The American Academy of Neurology (AAN) has released an evidence-based guideline for the assessment and management of athletes with concussion. This new guideline replaces the 1997 AAN guideline on the same... More

2013 International Stroke Conference

<p>
	Endovascular Therapy May Provide No Benefit When Combined With t-PA</p>

Endovascular Therapy May Provide No Benefit When Combined With t-PA

HONOLULU—Functional and safety outcomes were not significantly different between patients with acute ischemic stroke treated with IV t-PA and those treated with IV t-PA and endovascular therapy, said investigators at the... More

1 2 3 4 5

News in the Spotlight

BREAKING NEWS from the 5th Cooperative Meeting of the CMSC/ACTRIMS—Anti-JCV Antibody Index Further Defines PML Risk

ORLANDO—In natalizumab-treated patients with multiple sclerosis (MS) and no prior immunosuppressant use, a higher anti-JCV antibody index correlates with an increased risk of progressive multifocal leukoencephalopathy (PML... More


BREAKING NEWS from the 5th Cooperative Meeting of the CMSC and ACTRIMS—Multipotent Adult Progenitor Cells May Become a Viable Treatment for MS

ORLANDO—Treatment of patients with multiple sclerosis (MS) with human multipotent adult progenitor cells may provide clinical benefit through modulation of immune status and promotion of remyelination, according to basic s... More


<p>
	BREAKING NEWS from the 5th Cooperative Meeting of the CMSC and ACTRIMS—Exercise Training Reduces Fatigue in Patients With MS</p>

ORLANDO—Exercise training is associated with a significant moderate reduction in fatigue among patients with multiple sclerosis (MS), according to data presented at the Fifth Cooperative Meeting of the Consortium of Multip... More


<p>
	BREAKING NEWS from the 5th Cooperative Meeting of the CMSC and ACTRIMS—Disease-Modifying Therapies Impact Quality of Life Differently for Men and Women</p>

ORLANDO—Treatment of patients with multiple sclerosis (MS) with human multipotent adult progenitor cells may provide clinical benefit through modulation of immune status and promotion of remyelination, according to basic s... More

 

News In Brief

New and Noteworthy Information—June 2013

Individuals older than 70 with nonmelanoma skin cancer may have a significantly reduced risk of developing Alzheimer’s disease, compared with individuals without nonmelanoma skin cancer, according to research published online ahead of print... More

 

Noteworthy in Neurology

Late-Life Depression Increases Risk of Dementia

Depression in late life can accelerate cognitive decline. A new study shows that depression in older adults significantly increased the risk of all-cause dementia, Alzheimer’s disease, and vascular dementia.


Depression... More


Alzheimer's Mortality Varies Widely Between States

The age-adjusted death rate for Alzheimer’s disease in Washington State was more than four times higher than the rate in Hawaii for 2010, according to a report from the Centers for Disease Control and Prevention.

Washington had a... More


Memory Loss in Older Adults Varies by Race/Ethnicity

Self-reported rates of confusion or memory loss and of related functional difficulties in adults aged 60 years and older varied considerably by race/ethnicity, according to a report from the Centers for Disease Control and... More


BREAKING NEWS from the 5th Cooperative Meeting of the CMSC and ACTRIMS—Disease-Modifying Therapies Impact Quality of Life Differently for Men and Women

ORLANDO—Treatment of patients with multiple sclerosis (MS) with human multipotent adult progenitor cells may provide clinical benefit through modulation of immune status and promotion of remyelination, according to basic... More


BREAKING NEWS from the 5th Cooperative Meeting of the CMSC and ACTRIMS—Exercise Training Reduces Fatigue in Patients With MS

ORLANDO—Exercise training is associated with a significant moderate reduction in fatigue among patients with multiple sclerosis (MS), according to data presented at the Fifth Cooperative Meeting of the Consortium of... More


BREAKING NEWS from the 5th Cooperative Meeting of the CMSC and ACTRIMS—Multipotent Adult Progenitor Cells May Become a Viable Treatment for MS
ORLANDO—Treatment of patients with multiple sclerosis (MS) with human multipotent adult progenitor cells may provide clinical benefit through modulation of immune status and promotion of remyelination, according to basic... More

BREAKING NEWS from the 5th Cooperative Meeting of the CMSC/ACTRIMS—Anti-JCV Antibody Index Further Defines PML Risk

ORLANDO—In natalizumab-treated patients with multiple sclerosis (MS) and no prior immunosuppressant use, a higher anti-JCV antibody index correlates with an increased risk of progressive multifocal leukoencephalopathy... More


Planning Rescue Treatment Early Can Prevent Emergency Room Visits for Headache

STOWE, VERMONT—Advance planning for rescue therapy can prevent the need for a patient with headache to visit the emergency room, Rebecca Burch, MD, stated at the 23rd Annual Winter Headache Symposium of the Headache... More


A New World of Prevention and Treatment for Stroke?

2013 International Stroke Conference

A New World of Prevention and Treatment for Stroke?

HONOLULU—What if you could scan your patients for stroke-susceptibility loci or implant a device in their brains to repair stroke-damaged pathways?


Such forward-thinking concepts may be achievable,... More


FDG–PET May Be the Strongest Predictor of Alzheimer’s Dementia in MCI

SAN DIEGO—Of the items in the most current Alzheimer’s disease diagnostic criteria, PET imaging with 18-fluorodeoxyglucose is the strongest individual positive predictive biomarker of short-term incident dementia in mild... More


COMMENTARY—Chronic Widespread Pain and Small-Fiber Polyneuropathy

The word pain originates from the Latin word poena, meaning punishment, an accurate descriptor of how chronic pain affects the daily lives of millions of afflicted individuals. A 2011 Institute of Medicine report, Relieving Pain in... More


Unexplained Widespread Pain Syndrome? It May Be Small-Fiber Polyneuropathy

In a large series of adult and pediatric patients with juvenile-onset, unexplained, chronic widespread pain, more than half met rigorous, multi-test diagnostic criteria for small-fiber polyneuropathy (SFPN), according to a report in the... More


Fingolimod Slows MS Brain Atrophy Within Six Months

SAN DIEGO—Fingolimod slows brain atrophy in patients with multiple sclerosis (MS) and is the only approved drug that does so within the first six months of treatment, reported Jeffrey Cohen, MD, at the 65th Annual Meeting... More


A Glimpse Into the New DSM-5

The publication of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) on May 27 marks the first time that the influential diagnostic manual has been updated in nearly 20 years. The goal... More


Concussion May Lead to High Depression Rate in Retired NFL Players

SAN DIEGO—Among older retired players from the National Football League (NFL) who have a history of concussion, about 40% have mild to moderate symptoms of depression, a rate nearly three times higher than that of the... More


Could an Antibody Prevent Migraine?

To prevent migraine attacks, neurologists commonly prescribe drugs designed to treat epilepsy, high blood pressure, or depression. Monoclonal antibodies currently in development could one day become the first prophylactic therapies... More


Is PTSD a Precursor to Psychogenic Nonepileptic Seizures in Veterans?

SAN DIEGO—Post-traumatic stress disorder (PTSD) preceded a diagnosis of psychogenic nonepileptic seizures in 58% of military veterans and a diagnosis of epileptic seizures in 14% of military veterans, according to Martin... More


Patients Who Undergo Embolectomy May Remain at High Risk for Subsequent Stroke

HONOLULU—Patients admitted to the hospital with ischemic stroke who undergo embolectomy may still have a substantially increased risk of subsequent ischemic stroke. In research presented at the 2013 International Stroke... More


COMMENTARY—Inappropriate Control Group Compromises Study Results

There is a known risk of stroke whenever surgery or intravascular treatments are performed on brain-supplying blood vessels. That risk involves complications immediately or soon after the intervention, as well as a subsequent risk of... More


New Approaches Have Not Increased the Rate of Epilepsy Surgery

BETHESDA, MARYLAND—Surgery cures half of patients with refractory temporal lobe epilepsy, yet it is still highly underused, in part because of misperceptions about the risks and benefits, according to Edward F. Chang,... More


Which Factors Predict Seizure Recurrence After Epilepsy Surgery?

SAN DIEGO—Resective surgery is a successful treatment for many patients with intractable epilepsy, but the risk factors for seizure recurrence have been unclear. A study presented at the 65th Annual Meeting of the American... More


Simvastatin May Reduce Brain Atrophy in Patients With Secondary Progressive MS

SAN DIEGO—Simvastatin may reduce the rate of brain atrophy by approximately 40% in patients with secondary progressive multiple sclerosis (SPMS), according to data presented at the 65th Annual Meeting of the American... More


Attention and Visuospatial Ability May Predict Quality of Life After Stroke

HONOLULU—Attention and visuospatial ability three months after stroke may be strong predictors of patients’ long-term quality of life. Mental processing speed in the acute stage, particularly choice reaction time, also may... More


How Accurate Are International Prevalence Estimates for Neurologic Conditions?

SAN DIEGO—Epidemiologic studies of neurologic conditions have inconsistent methodologies that result in differing estimates of disease prevalence, according to research presented at the 65th Annual Meeting of the American... More


New Delivery Methods for Established Migraine Drugs Are on the Horizon

STOWE, VERMONT—Headache therapies of the near future will include new delivery routes for established medications, as well as comparatively new nerve-stimulation techniques, according to an overview presented at the 23rd... More


DTI May Detect Axonal Injury After Sports-Related Concussion

SAN DIEGO—Diffusion tensor imaging (DTI) may help neurologists detect axonal injury before any symptoms appear in an athlete who has had a concussion, said Jeffrey J. Bazarian, MD, MPH. Neurologists can maximize the... More


Preclinical Brain Amyloid Deposition Is Linked to Poor Sleep

Preclinical beta-amyloid deposition in the brains of cognitively normal volunteers was associated with poor sleep quality, but not sleep quantity, according to a study published in the May issue of JAMA Neurology.

More


Amyloid Imaging May Have Clinical Benefits for Patients With Suspected Dementia

SAN DIEGO—Despite arguments to the contrary, amyloid imaging can have clinical benefits for patients with suspected dementia, according to research presented at the 65th Annual Meeting of the American Academy of Neurology.... More

 

Multimedia

 
FEATURED VIDEO






FEATURED AUDIO






 
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT